Metabolic Health Matters, Whatever Your Size With PCOS/PMOS

Obesity Increased Risk, But Lean PCOS/PMOS Was Not Risk-Free

The researchers divided participants into lean and higher-weight groups based on BMI. Compared with the lean group, women in the higher-weight group generally had:

• Higher blood sugar
• Higher cholesterol and triglycerides
• Higher blood pressure
• Higher testosterone
• Greater waist circumference
• A higher prevalence of metabolic syndrome

However, metabolic syndrome was also identified in women with lean PCOS/PMOS. This reinforces that metabolic health deserves attention regardless of body size.

What Is Metabolic Syndrome?

Metabolic syndrome is not one single condition. It describes a group of metabolic changes that occur together and increase the long-term risk of type 2 diabetes and cardiovascular disease.

In this study, metabolic syndrome was diagnosed when someone had at least three of the following:

• Increased waist circumference
• Elevated fasting blood glucose
• Elevated triglycerides
• Low HDL cholesterol
• Elevated blood pressure

These markers help provide a broader picture of how effectively the body is regulating blood sugar, blood fats and cardiovascular health.

Which Metabolic Health Markers Should Be Checked?

One of the most practical messages from this research is that metabolic screening should not be reserved only for women who are overweight.

The key markers assessed in this study included:

• Waist circumference: This can help identify increased abdominal or visceral fat.

• Blood pressure: Regular monitoring can identify changes that may otherwise go unnoticed.

• Fasting blood glucose: This assesses the amount of glucose in the blood after fasting.

• Triglycerides: Elevated levels can be associated with insulin resistance and increased cardiovascular risk.

• HDL cholesterol: This is often known as “good” cholesterol. Lower levels can be one component of metabolic syndrome.

The researchers also measured additional markers, including total cholesterol, LDL cholesterol, an oral glucose tolerance test and several reproductive and thyroid hormones.

The exact tests that are appropriate will depend on the individual, but the findings support looking beyond weight and considering a broader metabolic assessment.

Symptoms Were Often More Common In The Higher-Weight Group

Women in the higher-weight group were more likely to experience several common features of PCOS/PMOS, including infertility, recent weight gain, irregular sleep, mood changes, excess androgen-related symptoms such as hirsutism and hair thinning, and acanthosis nigricans. Acanthosis nigricans refers to areas of darker, thicker or velvety skin, most commonly around the neck, underarms or skin folds, and can sometimes be a visible sign of elevated insulin levels or insulin resistance.

Importantly, many of these symptoms were also seen in women with lean PCOS/PMOS. This reinforces that while excess weight may increase the severity or frequency of some symptoms, lean PCOS/PMOS remains a genuine hormonal and metabolic condition that should not be overlooked simply because someone has a lower body weight.

Insulin Resistance May Connect Hormonal And Metabolic Symptoms

Insulin resistance is one of the key processes connecting the reproductive, hormonal and metabolic features of PCOS/PMOS. When the body becomes less responsive to insulin, it may produce more insulin to help keep blood glucose within a normal range. These higher insulin levels can encourage the ovaries to produce more androgens and may also reduce sex hormone-binding globulin, which can increase the amount of active testosterone circulating in the body.

Over time, this relationship contributes to irregular ovulation and menstrual cycles, acne, excess facial or body hair, hair thinning, increased abdominal fat, and higher blood glucose and triglyceride levels.

Lean PCOS/PMOS Still Deserves Thorough Investigation

One of the biggest misconceptions surrounding PCOS/PMOS is that someone who is lean cannot have significant insulin resistance or metabolic dysfunction.

This study challenges that assumption.

Although metabolic syndrome was more common in the higher-weight group, it was not limited to that group. Women with lean PCOS/PMOS also experienced metabolic and hormonal abnormalities.

A person may have a BMI within the normal range while still experiencing changes in blood glucose, insulin function, cholesterol or androgen levels.

This is why appearance alone should not be used to determine whether metabolic testing or support is needed.

Weight Is Only One Part Of The Picture

The findings do not suggest that body weight is irrelevant. Higher body weight, particularly increased abdominal fat, was associated with greater metabolic risk and more pronounced changes in several health markers. However, weight is only one part of a much larger picture.

Genetics, insulin sensitivity, hormone levels, fat distribution, physical activity, nutrition, sleep, stress and age can all influence metabolic health. This supports a more individualised approach to PCOS/PMOS care, rather than assuming that every person has the same risks or requires the same support.

Support Should Be Personalised

The researchers emphasised that PCOS/PMOS management should be tailored to the individual’s age, BMI, symptoms, metabolic markers and other health concerns.

For someone carrying excess weight, gradual and sustainable weight loss may improve insulin sensitivity and reduce metabolic risk.

For someone with lean PCOS/PMOS, weight loss may not be appropriate. The focus may instead be on maintaining a healthy weight while supporting blood sugar regulation, cardiovascular health, muscle mass and hormone balance.

In both groups, foundational strategies may include:

• Balanced meals containing protein, fibre, nourishing fats and appropriate carbohydrates
• Regular movement and resistance exercise
• Adequate sleep
• Supporting stress regulation
• Regular metabolic health monitoring

The goal is not simply to change the number on the scales. It is to improve how the body functions.

Early Screening Matters

Metabolic changes can develop quietly, without obvious symptoms.

Someone may not feel that their blood pressure, cholesterol or glucose regulation has changed. Regular screening can help identify these changes before they develop into more significant health concerns.

The authors concluded that women with PCOS/PMOS should be assessed for cardio-metabolic risk regardless of their age, weight or BMI.

This is particularly important for lean women who may otherwise be overlooked because they do not fit the body type commonly associated with PCOS/PMOS.

What This Means For PCOS/PMOS

This research reinforces that PCOS/PMOS is not simply a reproductive condition or a condition defined by body weight.

It can affect hormone production, insulin sensitivity, blood glucose regulation, cholesterol, blood pressure and long-term cardiovascular health.

Women in higher-weight bodies may face a greater likelihood of metabolic complications, but lean women are not automatically protected. Both groups may benefit from appropriate metabolic testing and personalised support.

The most important message is that care should be guided by what is happening inside the body, rather than assumptions based on appearance or BMI alone.

Understanding your individual hormonal and metabolic picture can make it easier to choose strategies that support both current symptoms and long-term health.